FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-003051-37-FI
Enrollment
Unknown
Registered
2013-07-16
Start date
2013-08-28
Completion date
Unknown
Last updated
2013-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 16.0 Level: PT Classification code 10023469 Term: Knee arthroplasty System Organ Class: 10042613 - Surgical and medical procedures MedDRA version: 16.0 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 100000004863

Interventions

Trade Name: Ketesse Product Name: Ketesse Pharmaceutical Form: Injection INN or Proposed INN: DEXKETOPROFEN (AS TROMETAMOL) Pharmaceutical form of the placebo: Injection Route of administration of the

Sponsors

Kuopion yliopistollinen sairaala
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Contacts

Public ContactMerja Kokki

Kuopion yliopistollinen sairaala

358447174764

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026